COCRYSTAL PHARMA, INC. Depreciation
COCRYSTAL PHARMA, INC. (COCP) reported Depreciation of $4.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-11-13
- COCRYSTAL PHARMA, INC. depreciation for the quarter ending 2023-09-30 was -$158.00K.
- COCRYSTAL PHARMA, INC. depreciation for the quarter ending 2023-06-30 was $117.00K.
- COCRYSTAL PHARMA, INC. depreciation for the quarter ending 2023-03-31 was $45.00K.
- COCRYSTAL PHARMA, INC. depreciation for the quarter ending 2019-03-31 was $23.00K, a 53.33% increase year-over-year.
- COCRYSTAL PHARMA, INC. depreciation for fiscal 2018 was $50.00K, a 50.50% decline from fiscal 2017.
- COCRYSTAL PHARMA, INC. depreciation for fiscal 2017 was $101.00K, a 49.75% decline from fiscal 2016.
- COCRYSTAL PHARMA, INC. depreciation for fiscal 2016 was $201.00K, a 4.69% increase from fiscal 2015.
- COCRYSTAL PHARMA, INC. depreciation for fiscal 2015 was $192.00K, a 3.52% decline from fiscal 2014.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 87 month |
|---|---|---|---|---|---|
| 2023-09-30 | -$158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$41.00K derived: sum of 2 quarters · filed 2023-11-13 | $4.00K 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $162.00K 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $45.00K 10-Q · filed 2023-05-15 | ||||
| 2019-03-31 | $23.00K 10-Q · filed 2019-05-10 | ||||
| 2018-12-31 | $50.00K 10-K · filed 2019-04-01 | ||||
| 2018-03-31 | $15.00K 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | $101.00K 10-K · filed 2019-04-01 | ||||
| 2016-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $92.00K derived: sum of 2 quarters · filed 2018-03-21 | $145.00K derived: sum of 3 quarters · filed 2018-03-21 | $201.00K 10-K · filed 2018-03-21 | |
| 2016-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $103.00K derived: sum of 2 quarters · filed 2016-11-09 | $159.00K 10-Q · filed 2016-11-09 | $218.00K derived: sum of 4 quarters · filed 2018-03-21 | |
| 2016-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $109.00K 10-Q · filed 2016-08-09 | $168.00K derived: sum of 3 quarters · filed 2018-03-21 | $213.00K derived: sum of 4 quarters · filed 2018-03-21 | |
| 2016-03-31 | $56.00K 10-Q · filed 2016-05-10 | $115.00K derived: sum of 2 quarters · filed 2018-03-21 | $160.00K derived: sum of 3 quarters · filed 2018-03-21 | $203.00K derived: sum of 4 quarters · filed 2018-03-21 | |
| 2015-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $104.00K derived: sum of 2 quarters · filed 2018-03-21 | $147.00K derived: sum of 3 quarters · filed 2018-03-21 | $192.00K 10-K · filed 2018-03-21 | |
| 2015-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $88.00K derived: sum of 2 quarters · filed 2016-11-09 | $133.00K 10-Q · filed 2016-11-09 | $178.00K derived: sum of 4 quarters · filed 2017-03-31 | |
| 2015-06-30 | $43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $88.00K 10-Q · filed 2016-08-09 | $133.00K derived: sum of 3 quarters · filed 2017-03-31 | $180.00K derived: sum of 4 quarters · filed 2017-03-31 | |
| 2015-03-31 | $45.00K 10-Q · filed 2016-05-10 | $90.00K derived: sum of 2 quarters · filed 2017-03-31 | $137.00K derived: sum of 3 quarters · filed 2017-03-31 | $187.00K derived: sum of 4 quarters · filed 2017-03-31 | |
| 2014-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $92.00K derived: sum of 2 quarters · filed 2017-03-31 | $142.00K derived: sum of 3 quarters · filed 2017-03-31 | $199.00K 10-K · filed 2017-03-31 | |
| 2014-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $97.00K derived: sum of 2 quarters · filed 2015-11-16 | $154.00K 10-Q · filed 2015-11-16 | $212.00K derived: sum of 4 quarters · filed 2015-11-16 | |
| 2014-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $107.00K 10-Q · filed 2015-08-14 | $165.00K derived: sum of 3 quarters · filed 2015-08-14 | $224.00K derived: sum of 4 quarters · filed 2015-08-14 | |
| 2014-03-31 | $57.00K 10-Q · filed 2015-05-14 | $115.00K derived: sum of 2 quarters · filed 2015-05-14 | $174.00K derived: sum of 3 quarters · filed 2015-05-14 | $233.00K derived: sum of 4 quarters · filed 2015-05-14 | $793.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $117.00K derived: sum of 2 quarters · filed 2015-03-31 | $176.00K derived: sum of 3 quarters · filed 2015-03-31 | $236.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $118.00K derived: sum of 2 quarters · filed 2014-11-14 | $178.00K 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $119.00K 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | $60.00K 10-Q · filed 2014-05-15 | ||||
| 2011-09-30 | $205.35K 10-Q · filed 2011-11-21 | $372.00K 10-Q · filed 2011-11-21 | |||
| 2010-09-30 | $87.87K 10-Q · filed 2011-11-21 | $249.47K 10-Q · filed 2011-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |